Science Explorer Back to mapMap
Discussion
Researcher · Institut Claudius Regaud · France

Amélie Lusque

Amélie Lusque publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0001-9691-5536 OpenAlex
World rank
#874,119
of 7,710,434 ranked researchers
Rank in France
#41,912
of 324,115
Works
132
Citations
4.7k
Citations per work
35.8
h-index
27
i10-index 49Top 14% in Oncology
Amélie Lusque

What does Amélie Lusque research?

Amélie Lusque's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 78 works · 58.9% of their workMedicine: 78 works · 58.9% of their workOncology: 30 works · 23.0% of their workPulmonary and Respiratory Medicine: 27 works · 20.5% of their workSurgery: 9 works · 6.8% of their workRadiology, Nuclear Medicine and Imaging: 7 works · 5.1% of their workGenetics: 5 works · 3.5% of their workEverything else: 40 works · 30.3% of their workLife Sciences: 14 works · 10.8% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 10.8% of their workCancer Research: 14 works · 10.8% of their workTHEIR WORKAmélie Lusque132works
Life Sciences11%Health Sciences59%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7858.9%
  2. Everything else4030.3%
    1. Biochemistry, Genetics and Molecular Biology1410.8%
  1. 1Oncology23% of their works
  2. 2Pulmonary and Respiratory Medicine20% of their works
  3. 3Cancer Research11% of their works
  4. 4Surgery7% of their works
  5. 5Radiology, Nuclear Medicine and Imaging5% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Amélie Lusque's research?

The keywords of their largest research topics: Metastatic Breast Cancer, Radiotherapy, Clinical Practice Guidelines, Survival Analysis, Breast Cancer, CDK4/6 Inhibitors, Targeted Therapy and Breast Tumours.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Metastatic Breast Cancer462 topics
  2. Radiotherapy372 topics
  3. Clinical Practice Guidelines362 topics
  4. Survival Analysis362 topics
  5. Breast Cancer341 topic
  6. CDK4/6 Inhibitors341 topic
  7. Targeted Therapy272 topics
  8. Breast Tumours251 topic
  9. Gene Expression251 topic
  10. Molecular Classification232 topics
  11. Immune Checkpoint Blockade221 topic
  12. PD-1 and PD-L1221 topic
  13. Cancer Genomics141 topic
  14. Mutational Signatures141 topic
  15. ALK Inhibitors131 topic
  16. EGFR Mutations131 topic
  17. Chemotherapy-Induced Peripheral Neuropathy121 topic
  18. Glioblastoma121 topic
  19. Taxanes121 topic
  20. Temozolomide121 topic
  21. Cervical Cancer111 topic
  22. Endometrial Carcinoma111 topic

Where does Amélie Lusque work?

Amélie Lusque's main affiliation in the publication record is Institut Claudius Regaud, France.

How many publications and citations does Amélie Lusque have?

OpenAlex counts 132 works and 4,723 citations for Amélie Lusque, an h-index of 27, ranking #874,119 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Amélie Lusque. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.